Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Brooks

Showing results (1141-1150 of 1,175) with videos related to

Pageof 118
Sort By:
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 11, 2022
Analysis of separate training and validation radical prostatectomy cohorts identifies 0.25 mm diameter as an optimal definition for "large" cribriform prostatic adenocarcinomaEmily Chan, Jesse K McKenney, Sarah Hawley, et al.
Cancers|May 13, 2026
Contribution of Risk Factors, Including Polygenic Score, to the Multifactorial Risk Assessment for the Implementation of Personalized Breast Cancer Screening: Insights from the PERSPECTIVE: Integration and Implementation ProjectXin Yang, Juliet A Usher-Smith, Kristina M Blackmore, et al.
JAMA Network Open|September 28, 2019
Association of a Pathway-Specific Genetic Risk Score With Risk of Radiation-Associated Contralateral Breast CancerGordon P Watt, Anne S Reiner, Susan A Smith, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 19, 2024
Upgrading of Grade Group 1 Prostate Cancer at Prostatectomy: Germline Risk Factors in a Prospective CohortMichael A Liss, Nicole Zeltser, Yingye Zheng, et al.
Human Pathology|February 17, 2022
Development and validation of a quantitative reactive stroma biomarker (qRS) for prostate cancer prognosisSamuel Ruder, Yan Gao, Yi Ding, et al.
Cell Reports. Medicine|March 4, 2022
SU086, an inhibitor of HSP90, impairs glycolysis and represents a treatment strategy for advanced prostate cancerMeghan A Rice, Vineet Kumar, Dhanir Tailor, et al.
Circulation|December 5, 2024
Sickle Trait and Alpha Thalassemia Increase NOS-Dependent Vasodilation of Human Arteries Through Disruption of Endothelial Hemoglobin-eNOS InteractionsSteven D Brooks, A Parker Ruhl, Xianke Zeng, et al.
Advances in Anatomic Pathology|December 13, 2012
A model for the design and construction of a resource for the validation of prognostic prostate cancer biomarkers: the Canary Prostate Cancer Tissue MicroarraySarah Hawley, Ladan Fazli, Jesse K McKenney, et al.
Journal of Personalized Medicine|July 2, 2021
Personalized Risk Assessment for Prevention and Early Detection of Breast Cancer: Integration and Implementation (PERSPECTIVE I&I)Jennifer D Brooks, Hermann H Nabi, Irene L Andrulis, et al.
Scientific Reports|August 18, 2023
Dynamic interplay between sortilin and syndecan-1 contributes to prostate cancer progressionJoanna Lazniewska, Ka Lok Li, Ian R D Johnson, et al.
Pageof 118

Showing results (1141-1150 of 1,175) with videos related to

Sort By:
Pageof 118
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 11, 2022
Analysis of separate training and validation radical prostatectomy cohorts identifies 0.25 mm diameter as an optimal definition for "large" cribriform prostatic adenocarcinomaEmily Chan, Jesse K McKenney, Sarah Hawley, et al.
Cancers|May 13, 2026
Contribution of Risk Factors, Including Polygenic Score, to the Multifactorial Risk Assessment for the Implementation of Personalized Breast Cancer Screening: Insights from the PERSPECTIVE: Integration and Implementation ProjectXin Yang, Juliet A Usher-Smith, Kristina M Blackmore, et al.
JAMA Network Open|September 28, 2019
Association of a Pathway-Specific Genetic Risk Score With Risk of Radiation-Associated Contralateral Breast CancerGordon P Watt, Anne S Reiner, Susan A Smith, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 19, 2024
Upgrading of Grade Group 1 Prostate Cancer at Prostatectomy: Germline Risk Factors in a Prospective CohortMichael A Liss, Nicole Zeltser, Yingye Zheng, et al.
Human Pathology|February 17, 2022
Development and validation of a quantitative reactive stroma biomarker (qRS) for prostate cancer prognosisSamuel Ruder, Yan Gao, Yi Ding, et al.
Cell Reports. Medicine|March 4, 2022
SU086, an inhibitor of HSP90, impairs glycolysis and represents a treatment strategy for advanced prostate cancerMeghan A Rice, Vineet Kumar, Dhanir Tailor, et al.
Circulation|December 5, 2024
Sickle Trait and Alpha Thalassemia Increase NOS-Dependent Vasodilation of Human Arteries Through Disruption of Endothelial Hemoglobin-eNOS InteractionsSteven D Brooks, A Parker Ruhl, Xianke Zeng, et al.
Advances in Anatomic Pathology|December 13, 2012
A model for the design and construction of a resource for the validation of prognostic prostate cancer biomarkers: the Canary Prostate Cancer Tissue MicroarraySarah Hawley, Ladan Fazli, Jesse K McKenney, et al.
Journal of Personalized Medicine|July 2, 2021
Personalized Risk Assessment for Prevention and Early Detection of Breast Cancer: Integration and Implementation (PERSPECTIVE I&I)Jennifer D Brooks, Hermann H Nabi, Irene L Andrulis, et al.
Scientific Reports|August 18, 2023
Dynamic interplay between sortilin and syndecan-1 contributes to prostate cancer progressionJoanna Lazniewska, Ka Lok Li, Ian R D Johnson, et al.
Pageof 118